Blinding in Clinical Trials: Seeing the Big Picture

Blinding mitigates several sources of bias which, if left unchecked, can quantitively affect study outcomes. Blinding remains under-utilized, particularly in non-pharmaceutical clinical trials, but is often highly feasible through simple measures. Although blinding is generally viewed as an effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Monaghan, Thomas F., Agudelo, Christina W., Rahman, Syed N., Wein, Alan J., Lazar, Jason M., Everaert, Karel, Dmochowski, Roger R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308085/
https://www.ncbi.nlm.nih.gov/pubmed/34202486
http://dx.doi.org/10.3390/medicina57070647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308085/
https://www.ncbi.nlm.nih.gov/pubmed/34202486
http://dx.doi.org/10.3390/medicina57070647

Ejemplares similares